Cite
HARVARD Citation
Mallett, A. et al. (2015). Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort. Internal medicine journal. 45 (10), pp. 1054-1065. [Online].